Record Details

Targeting of Parasite-Specific Immunoliposome-Encapsulated Doxorubicin in the Treatmentof Experimental Visceral Leishmaniasis

EPrints@IICB

View Archive Info
 
 
Field Value
 
Title Targeting of Parasite-Specific Immunoliposome-Encapsulated Doxorubicin in the Treatmentof Experimental Visceral Leishmaniasis
 
Creator Mukherjee, Snigdha
Das, Lopamudra
Kole, Labanyamoy
Karmakar, Sudipan
Datta, Neeta
Das, Pijush K
 
Subject Infectious Diseases and Immunology
 
Description A parasite-specific 51-kDa protein has been isolated from the membrane of macrophages infected with Leishmania
donovani, the causative agent of visceral leishmaniasis. Active targeting of doxorubicin to infected macrophages was studied by incorporating it in immunoliposomes prepared by grafting F(ab)�2 of anti–51-kDa antibody onto the liposomal surface. In a 45-day mouse model of visceral leishmaniasis, complete elimination of spleen parasite burden was achieved by doxorubicin incorporated in immunoliposome (immunodoxosome) at a dose of 250 mg/kg/day that was given for 4 consecutive days. A similar dose of free and
liposomal drug (doxosome) had 45% and 84% parasite suppressive effects, respectively. Immunodoxosome and doxosome were generally less toxic than the free drug, as determined by several clinical parameters of cardiotoxicity and liver toxicity. These results not only indicate the potential of doxorubicin as an effective chemotherapeutic agent but also establish the use of immunoliposomes as drug carrier in the therapy of leishmaniasis.
 
Publisher University of Chicago Press
 
Date 1993
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/2314/1/JOURNAL_OF_INFECTIOUS_DISEASES__V._168___(_4_)_994%2D999;1993[20].pdf
Mukherjee, Snigdha and Das, Lopamudra and Kole, Labanyamoy and Karmakar, Sudipan and Datta, Neeta and Das, Pijush K (1993) Targeting of Parasite-Specific Immunoliposome-Encapsulated Doxorubicin in the Treatmentof Experimental Visceral Leishmaniasis. The Journal of Infectious Diseases, 168 (4). pp. 994-999.
 
Relation http://www.eprints.iicb.res.in/2314/